Published on 18 Apr 2022 on MSN News
Pharma Q4 Preview | Despite strong domestic demand and modest US growth, cost pressure, lower prices...
Raw material prices aggravated due to COVID-led lockdowns in China and spike in logistics costs to...
NSE.CIPLA price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free